InfoNet Logo  

New Mexico AIDS InfoNet Fact Sheet Number 421

ddC (Hivid)


Eslabón a la Versión Español

 PrinterPrint

this Fact Sheet on a single page using:

 Microsoft Word

Adobe Acrobat

 More information on Downloading

& Printing Fact Sheets


WHAT

IS ddC?

ddC (Hivid®), is a drug used for antiviral

therapy. It is manufactured by Roche. ddC is also known as

zalcitabine or dideoxycytidine.

ddC is a nucleoside analog reverse transcriptase inhibitor,

or nuke. These drugs block the reverse transcriptase enzyme. This

enzyme changes HIV’s genetic material (RNA) into the form of DNA.

This has to occur before HIV’s genetic code gets inserted into

an infected cell’s own genetic codes.


WHO SHOULD TAKE

ddC?

ddC was approved as an antiviral drug for people with HIV infection.

There are no absolute rules about when to start antiviral drugs.

You and your doctor should consider your T-cell count, your viral

load, any symptoms you are having, and your attitude about taking

HIV medications. Fact Sheet 411

has more information about guidelines

for the use of antiviral medications.

If you take ddC with other antiviral drugs, you can reduce

your viral load to extremely low levels, and increase your T-cell

counts. This should mean staying healthier longer.


WHAT ABOUT DRUG

RESISTANCE?

Many new copies of HIV are mutations. They are slightly different

from the original virus. Some mutations can keep multiplying

even when you are taking an antiviral drug. When this happens,

the drug will stop working. This is called “developing resistance”

to the drug. See Fact Sheet 414

for more information on resistance.

Sometimes, if your virus develops resistance to one drug, it

will also have resistance to other antiviral drugs. This is called

“cross-resistance”.

Resistance can develop quickly. It is very important to

take antiviral medications according to instructions, on schedule,

and not to skip or reduce doses.


HOW IS ddC TAKEN?

ddC is available in tablets of 0.75mg or 0.375mg. The normal

adult dose is one 0.75mg tablet three times a day.

ddC should be taken on an empty stomach: 2 hours after eating,

or 1 hour before a meal.

Be sure your doctor knows if you have had liver or kidney problems.

Your liver and kidney will have to be watched carefully if you

take ddC, and your doctor might decide that you should not use

ddC at all.


WHAT

ARE THE SIDE EFFECTS?

When you start any antiviral treatment you may have temporary

side effects such as headaches, hypertension, or a general sense

of feeling ill. These side effects usually get better or disappear

over time.

The most common side effects of ddC are rashes, chest pain,

fever, nausea, changes in liver function, and mouth sores.

The most serious side effects of ddC are peripheral

neuropathy and, in rare cases, pancreatitis.

Peripheral neuropathy is a form of nerve damage. It

usually shows up as tingling, numbness, or a sharp burning sensation

in the feet, legs, or hands. The nerve damage is usually temporary

and will go away if you stop taking ddC, or reduce the dose. If

you continue to take ddC after nerve damage shows up, it may become

permanent.

Pancreatitis is an inflammation of the pancreas, a large

gland located behind the stomach. Pancreatitis can be fatal. If

you are taking ddC and have sharp pain near your stomach, back,

or sides, with nausea and vomiting, you should stop taking ddC

immediately and call your doctor.


HOW DOES ddC

REACT WITH OTHER DRUGS?

ddC is more effective if taken with other antiviral

drugs.

ddC should not be combined with 3TC (lamivudine, Epivir®),

d4T (stavudine, Zerit®), or ddI (didanosine, Videx®).

Blood levels of ddC may be decreased by antacids or

cimetidine.

Blood levels of ddC may be increased by aminoglycosides,

amphotericin B, foscarnet, or probenecid.

Several other medications can make the side effects of ddC

worse. Be sure your doctor knows about all the medications you

are taking.


Revised February

7, 2002

HomeGo

to InfoNet Main Page

Card FileGo to

Index of Fact Sheets

Question markClick

here if you have questions

The New Mexico AIDS InfoNet is a project of the

New Mexico AIDS Education and Training Center

Partially funded by the National Library of Medicine

and the New Mexico Department of Health